Correlation Between Neuropace and Baxter International

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neuropace and Baxter International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Baxter International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Baxter International, you can compare the effects of market volatilities on Neuropace and Baxter International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Baxter International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Baxter International.

Diversification Opportunities for Neuropace and Baxter International

-0.75
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Neuropace and Baxter is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Baxter International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Baxter International and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Baxter International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Baxter International has no effect on the direction of Neuropace i.e., Neuropace and Baxter International go up and down completely randomly.

Pair Corralation between Neuropace and Baxter International

Given the investment horizon of 90 days Neuropace is expected to generate 4.38 times more return on investment than Baxter International. However, Neuropace is 4.38 times more volatile than Baxter International. It trades about 0.31 of its potential returns per unit of risk. Baxter International is currently generating about -0.22 per unit of risk. If you would invest  714.00  in Neuropace on September 13, 2024 and sell it today you would earn a total of  394.00  from holding Neuropace or generate 55.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Neuropace  vs.  Baxter International

 Performance 
       Timeline  
Neuropace 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.
Baxter International 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Baxter International has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Neuropace and Baxter International Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neuropace and Baxter International

The main advantage of trading using opposite Neuropace and Baxter International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Baxter International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Baxter International will offset losses from the drop in Baxter International's long position.
The idea behind Neuropace and Baxter International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device